6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 16H43

Chengdu Brilliant Pharmaceutical Group.Inc

About Chengdu Brilliant Pharmaceutical Group.Inc

Chengdu Brilliant Pharmaceutical Co., Ltd. ( Brilliant Pharmaceutical ) is a high-tech enterprise specializing in pharmaceutical innovation and the R&D, production, and sales of high-quality medicines. Committed to four major R&D directions—specialty active pharmaceutical ingredients (APIs), high-end generics, innovative drugs, and novel drug delivery systems—it has built a full-chain pharmaceutical ecosystem spanning intermediates, APIs, and formulations, covering chemical drugs (including radiopharmaceuticals), biologics, and traditional Chinese medicines.

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 16H43
  • Country/Region:
    China
  • On CPHI since:
    2026
Contact info
  • No.265, Hexiang 3rd Street, Hi-Tech Development Zone,, Chengdu,, China

Products from Chengdu Brilliant Pharmaceutical Group.Inc (5)

  • Azithromycin for Injection

    Product Azithromycin for Injection

    Azithromycin for Injection is a macrolide antibiotic used for susceptible bacterial infections of the respiratory tract, skin and soft tissue, and urogenital tract. It is given intravenously when oral therapy is not feasible or for more severe cases, often followed by oral step-down. It offers high tissue ...
  • Budesonide Inhalation Suspension

    Product Budesonide Inhalation Suspension

    Budesonide Inhalation Suspension provides potent local anti-inflammatory action in the airways, reduces airway hyperresponsiveness, and is delivered directly to the lungs via nebulization for fast onset with relatively low systemic exposure—helping improve asthma symptom control and reduce the risk of acut...
  • Gadoxetate Disodium Injection

    Product Gadoxetate Disodium Injection

    Gadoxetate Disodium Injection is a liver-specific MRI contrast agent for enhanced imaging: dynamic phase shows perfusion, hepatobiliary phase highlights lesion–liver contrast. It improves detection and characterization of small HCC and metastases, offers better lesion contrast, no ionizing radiation, and a...
  • Pembrolizumab biosimilar

    Product Pembrolizumab biosimilar

    Pembrolizumab biosimilar is an anti–PD-1 monoclonal antibody that blocks PD-1/PD-L1 inhibition and activates T cells against tumors. It is used for multiple advanced cancers, such as non–small cell lung cancer, melanoma, head and neck squamous cell carcinoma, lymphoma, and MSI-H/dMMR tumor-agnostic indicat...
  • Semaglutide

    Product Semaglutide

    Semaglutide is a GLP-1 receptor agonist that stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon, delays gastric emptying, and reduces appetite. It is mainly used for glycemic control in type 2 diabetes; some doses are approved for weight management in obesity/overweight, with e...